Cunning Capital Partners’s Teladoc Health TDOC Stock Holding History

Cunning Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,330	Closed	-$1.51M	–	44
2021 Q1	$1.51M	Sell	8,330 -5,670	-41%	-$1.32M	0.94%	38
2020 Q4	$2.8M	Buy	14,000 +7,000	+100%	+$1.42M	1.5%	23
2020 Q3	$1.53M	Hold	7,000	–	–	0.97%	26
2020 Q2	$1.34M	Hold	7,000	–	–	0.94%	27
2020 Q1	$1.08M	Buy	+7,000	New	+$814K	1%	26

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cunning Capital Partners's TDOC Position: Q2 2021 in Review

Cunning Capital Partners sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 8,330 shares — an estimated $1.51M sold.

Cunning Capital Partners first reported a position in TDOC in Q1 2020 and held it in 5 quarters. The position peaked at $2.8M in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

Cunning Capital Partners reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
Cunning Capital Partners sold 8,330 Teladoc Health shares in Q2 2021, an estimated $1.51M.
Cunning Capital Partners first reported a position in Teladoc Health in Q1 2020 and held it in 5 quarters.
Cunning Capital Partners's Teladoc Health position peaked at $2.8M in Q4 2020.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Cunning Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.